Triple
T9569757
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Edinburgh BioQuarter |
E230883
|
entity |
| Predicate | hostsFacility |
P12416
|
FINISHED |
| Object |
Centre for Regenerative Medicine
The Centre for Regenerative Medicine is a leading research institute focused on stem cells and regenerative therapies, based at the University of Edinburgh.
|
E806860
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Centre for Regenerative Medicine | Statement: [Edinburgh BioQuarter, hostsFacility, Centre for Regenerative Medicine]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Centre for Regenerative Medicine Context triple: [Edinburgh BioQuarter, hostsFacility, Centre for Regenerative Medicine]
-
A.
Cambridge Stem Cell Institute
The Cambridge Stem Cell Institute is a leading research center at the University of Cambridge dedicated to understanding stem cell biology and translating this knowledge into new treatments for human disease.
-
B.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
C.
Massachusetts General Hospital Center for Regenerative Medicine
The Massachusetts General Hospital Center for Regenerative Medicine is a research and clinical center focused on developing stem cell and regenerative therapies to repair and replace damaged tissues and organs.
-
D.
Centre for Cancer Research and Cell Biology
The Centre for Cancer Research and Cell Biology is a major research institute at Queen’s University Belfast dedicated to advancing understanding of cancer biology and developing improved diagnostics and treatments.
-
E.
Life Sciences Centre
The Life Sciences Centre is a major research and teaching complex at the University of British Columbia dedicated to biological and biomedical sciences.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Centre for Regenerative Medicine Triple: [Edinburgh BioQuarter, hostsFacility, Centre for Regenerative Medicine]
Generated description
The Centre for Regenerative Medicine is a leading research institute focused on stem cells and regenerative therapies, based at the University of Edinburgh.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Centre for Regenerative Medicine Target entity description: The Centre for Regenerative Medicine is a leading research institute focused on stem cells and regenerative therapies, based at the University of Edinburgh.
-
A.
Cambridge Stem Cell Institute
The Cambridge Stem Cell Institute is a leading research center at the University of Cambridge dedicated to understanding stem cell biology and translating this knowledge into new treatments for human disease.
-
B.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
C.
Massachusetts General Hospital Center for Regenerative Medicine
The Massachusetts General Hospital Center for Regenerative Medicine is a research and clinical center focused on developing stem cell and regenerative therapies to repair and replace damaged tissues and organs.
-
D.
Centre for Cancer Research and Cell Biology
The Centre for Cancer Research and Cell Biology is a major research institute at Queen’s University Belfast dedicated to advancing understanding of cancer biology and developing improved diagnostics and treatments.
-
E.
Life Sciences Centre
The Life Sciences Centre is a major research and teaching complex at the University of British Columbia dedicated to biological and biomedical sciences.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ca847f22188190a56e4a97625bef22 |
completed | March 30, 2026, 2:11 p.m. |
| NER | Named-entity recognition | batch_69cd998940c881909f9025512cf72fe9 |
completed | April 1, 2026, 10:17 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69d152b5b40c81909a84e34a944abfd0 |
completed | April 4, 2026, 6:04 p.m. |
| NEDg | Description generation | batch_69d153c26b8481908298b32918666562 |
completed | April 4, 2026, 6:09 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69d15445e7a88190accd19c53a6170bb |
completed | April 4, 2026, 6:11 p.m. |
Created at: March 30, 2026, 8:04 p.m.